Literature DB >> 12172588

Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment.

Paul Grootendorst1.   

Abstract

INTRODUCTION: Federal legislation outlined in the Medical Care Act of 1966 and the Canada Health Act of 1984 stipulates that Canadian provincial governments are to administer insurance programs for "medically necessary" services provided by hospitals and physicians. The legislation did not mandate provincial government coverage for prescription drugs taken outside of the hospital. Each province has, however, provided coverage to senior citizens and social assistance recipients; some provinces have introduced drug coverage for the general public.
METHODS: The present paper reviews the history of the provincial drug insurance programs for these three beneficiary groups (seniors, social assistance recipients and the general public), from the inception dates of the programs to October 31, 2000. Attention is given to eligibility conditions and amounts of beneficiary cost sharing.
RESULTS: A review of the history of the provincial drug programs reveals a significant variation in the amounts of patient cost sharing between and within programs and over time. In addition, starting in the early 1990s, there was a trend in most provinces to increase the generosity of coverage for those with large drug expenses relative to income, irrespective of beneficiary age, typically at the expense of reduced coverage for senior citizens. Some implications of this trend are drawn in light of evidence of the deleterious effects of cost sharing targeted at senior citizens.

Entities:  

Mesh:

Year:  2002        PMID: 12172588

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  18 in total

1.  Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.

Authors:  Jamie R Daw; Steven G Morgan
Journal:  Health Policy       Date:  2011-10-05       Impact factor: 2.980

2.  Prescription drug coverage: an essential service or a fringe benefit?

Authors:  Robyn M Tamblyn
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

3.  Does Equity in Healthcare Use Vary across Canadian Provinces?

Authors:  Sara Allin
Journal:  Healthc Policy       Date:  2008-05

4.  The effect of pharmaceutical patent term length on research and development and drug expenditures in Canada.

Authors:  Paul Grootendorst; Livio Di Matteo
Journal:  Healthc Policy       Date:  2007-02

5.  Canadian pharmacare: looking back, looking forward.

Authors:  Steven G Morgan; Jamie R Daw
Journal:  Healthc Policy       Date:  2012-08

6.  Cost shifting and timeliness of drug formulary decisions in atlantic Canada.

Authors:  Andrea C Scobie; Neil J Mackinnon
Journal:  Healthc Policy       Date:  2010-02

7.  Should national pharmacare apply a value-based insurance design?

Authors:  Kai Yeung; Steven G Morgan
Journal:  CMAJ       Date:  2019-07-22       Impact factor: 8.262

8.  Re: "cost shifting and timeliness of drug formulary recommendations in atlantic canada," healthcare policy, vol. 5, no. 3, 2010.

Authors: 
Journal:  Healthc Policy       Date:  2010-08

9.  Coping strategies used by patients infected with hepatitis C virus who are facing medication costs.

Authors:  Chiranjeev Sanyal; Ethel Langille Ingram; Ingrid S Sketris; Kevork M Peltekian; Susan Kirkland
Journal:  Can J Hosp Pharm       Date:  2011-03

10.  Resident physician and hospital pharmacist familiarity with patient discharge medication costs.

Authors:  Kerry Wilbur
Journal:  Pharm World Sci       Date:  2009-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.